Gumprecht Jakub, Domek Magdalena, Proietti Marco, Li Yan-Guang, Asaad Nidal, Rashed Wafa, Alsheikh-Ali Alawi, Zubaid Mohammad, Lip Gregory Y H
Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool L7-8TX, UK.
Department of Cardiology, Medical University of Silesia, Silesian Centre for Heart Diseases, 41-800 Zabrze, Poland.
J Clin Med. 2020 Apr 29;9(5):1286. doi: 10.3390/jcm9051286.
Atrial fibrillation (AF) is associated with substantially increased risk of cardiovascular events and overall mortality. The Atrial fibrillation Better Care (-Avoid stroke, -Better symptom management, -Cardiovascular and comorbidity risk management) pathway provides a simple and comprehensive approach for integrated AF therapy. This study's goals were to evaluate the ABC pathway compliance and determine the main gaps in AF management in the Middle East population, and to assess the impact of ABC pathway adherence on the all-cause mortality and composite outcome in AF patients. 2021 patients (mean age 57; 52% male) from the Gulf SAFE registry were studied. We evaluated: A-appropriate implementation of OACs according to CHADS-VASc score; B-symptom control according to European Heart Rhythm Association (EHRA) symptom scale; C-proper cardiovascular comorbidities management. The primary endpoints were the composite cardiovascular outcome (ischemic stroke or systemic embolism, all-cause death and cardiovascular hospitalization) and all-cause mortality. One-hundred and sixty-eight (8.3%) patients were optimally managed according to adherence with the ABC pathway. Over the one-year follow up (FU), there were 578 composite outcome events and 224 deaths. Patients managed with integrated care had significantly lower rates for the composite outcome and mortality comparing to non-ABC group (20.8% vs. 29.3%, = 0.02 and 7.3% vs. 13.1%, = 0.033, respectively). On multivariable analysis, ABC compliance was independently associated with reduced risk of composite outcome (HR 0.53; 95% CI 0.36-0.8, = 0.002) and death (HR 0.46; 95% CI 0.25-0.86, = 0.015). Integrated ABC pathway adherent care resulted in the reduced composite outcome and all-cause mortality in AF patients from Middle East, highlighting the necessity of promoting comprehensive holistic and integrated care management of AF.
心房颤动(AF)与心血管事件风险和总体死亡率大幅增加相关。心房颤动优化治疗(-避免中风、-更好地管理症状、-管理心血管疾病和合并症)路径为综合房颤治疗提供了一种简单而全面的方法。本研究的目的是评估ABC路径的依从性,确定中东人群房颤管理中的主要差距,并评估ABC路径依从性对房颤患者全因死亡率和复合结局的影响。对海湾SAFE注册中心的2021例患者(平均年龄57岁;52%为男性)进行了研究。我们评估了:A-根据CHADS-VASc评分适当使用口服抗凝药(OACs);B-根据欧洲心律协会(EHRA)症状量表进行症状控制;C-正确管理心血管合并症。主要终点是复合心血管结局(缺血性中风或全身性栓塞、全因死亡和心血管住院)和全因死亡率。168例(8.3%)患者根据ABC路径依从性得到了最佳管理。在为期一年的随访(FU)中,有578例复合结局事件和224例死亡。与非ABC组相比,接受综合治疗的患者复合结局和死亡率显著更低(分别为20.8%对29.3%,P = 0.02;7.3%对13.1%,P = 0.033)。多变量分析显示,ABC依从性与复合结局风险降低独立相关(风险比[HR]0.53;95%置信区间[CI]0.36-0.8,P = 0.002)以及死亡风险降低独立相关(HR 0.46;95% CI 0.25-0.86,P = 0.015)。在中东房颤患者中,ABC路径的综合依从性护理可降低复合结局和全因死亡率,突出了促进房颤全面整体和综合护理管理的必要性。